ClinicalTrials.Veeva

Menu

A Comprehensive Smoking Cessation Intervention Duration Radiation for Upper Aerodigestive Cancers

Johns Hopkins Medicine logo

Johns Hopkins Medicine

Status

Completed

Conditions

Thoracic Neoplasms
Tobacco Use Disorder
Radiation
Head and Neck Neoplasms

Treatments

Other: Comprehensive smoking cessation intervention
Behavioral: Enhanced usual care

Study type

Interventional

Funder types

Other
NIH

Identifiers

NCT02188563
J1407
NA_00089912 (Other Identifier)
P50DE019032 (U.S. NIH Grant/Contract)

Details and patient eligibility

About

Smoking is the greatest risk factor for upper aerodigestive cancers (thoracic or head and neck) and negatively impacts survival and other outcomes, but many patients have difficulty quitting after their diagnosis. Smoking cessation interventions for cancer patients thus far have had limited success. This is a pilot randomized controlled trial designed to determine if a new comprehensive, evidence-based smoking cessation intervention can improve quit rates for cancer patients who smoke.

Enrollment

30 patients

Sex

All

Ages

18 to 105 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • New diagnosis of head and neck or thoracic (including lung) cancer
  • Undergoing radiation at Johns Hopkins Radiation Oncology for 5 or more weeks
  • English-speaking and able to provide informed consent
  • Smoked any cigarettes in previous 14 days

Exclusion criteria

  • Palliative radiation
  • Undergoing stereotactic radiosurgery
  • Pregnant or breastfeeding

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

None (Open label)

30 participants in 2 patient groups

Comprehensive intervention
Experimental group
Description:
New evidence-based comprehensive smoking cessation intervention including several elements that have proven successful in non-cancer patients but not used for cancer patients before.
Treatment:
Other: Comprehensive smoking cessation intervention
Enhanced usual care
Active Comparator group
Description:
Intervention consistent with the U.S. Department of Health and Human Services guidelines for tobacco treatment.
Treatment:
Behavioral: Enhanced usual care

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems